• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>GlaxoSmithKline

GlaxoSmithKline

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Novartis, GlaxoSmithKline Complete Deals

    Novartis, GlaxoSmithKline Complete Deals

  2. Novartis, GlaxoSmithKline Complete Series of Deals - Update

    Novartis, GlaxoSmithKline Complete Series of Deals - Update

  3. GSK Raises $854 Million From Aspen Pharmacare Share Sale

    GSK Raises $854 Million From Aspen Pharmacare Share Sale

  4. GSK Raises $854 Million from Aspen Share Sale

    GSK Raises $854 Million from Aspen Share Sale

  5. GSK Plans to Sell About Half Its 12.4% Stake in Aspen Pharmacare

    GSK Plans to Sell About Half Its 12.4% Stake in Aspen Pharmacare

  6. GSK Plans Partial Stake Sale in Aspen Pharmacare

    GSK Plans Partial Stake Sale in Aspen Pharmacare

  7. Research and Markets: Global HER-2 Positive Breast Cancer Market 2015-2019 with Celgene, F. Hoffmann-La Roche, GlaxoSmithKline , Novartis & Sanofi Dominating

    Research and Markets: Global HER-2 Positive Breast Cancer Market 2015-2019 with Celgene, F. Hoffmann-La Roche, GlaxoSmithKline , Novartis & Sanofi Dominating

  8. LONDON MARKETS: FTSE 100 Rises As Drug Makers, SABMiller Advance

    LONDON MARKETS: FTSE 100 Rises As Drug Makers, SABMiller Advance

  9. UPDATE: FTSE 100 rises as drug makers, SABMiller advance

    UPDATE: FTSE 100 rises as drug makers, SABMiller advance

  10. Street gushes over Alzheimer's drug, but some worry about overreaction

    Street gushes over Alzheimer's drug, but some worry about overreaction

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.